A judge has approved one of the largest mass-tort settlements in American history. St. Louis Circuit Judge Timothy Boyer granted final approval on Friday to Bayer’s $7.25 billion nationwide class settlement over claims that its Roundup weedkiller causes cancer. The judge called the total “among the largest in the history of mass tort personal-injury class action settlements”. The approval order is subject to appeal.
Under the deal, Bayer — which acquired Roundup maker Monsanto — will make declining capped annual payments for up to 21 years, totalling up to $7.25 billion. Individual payouts will range from $10,000 to $165,000 for people who developed non-Hodgkin lymphoma after Roundup exposure, depending on how much they used it, their age at diagnosis and the severity of their illness. The settlement covers both current claimants, exposed before 17 February 2026, and future claimants diagnosed with non-Hodgkin lymphoma within a 16-year period after final approval. It also includes $600 million in attorneys’ fees.
A decade of litigation
The Roundup litigation has weighed on Bayer for close to a decade, and chief executive Bill Anderson called the approval “a decisive milestone”. The ruling follows the US Supreme Court’s 7-2 Durnell decision in June, which limited failure-to-warn cases against the company. For the market backdrop to the week, see Nasdaq plunges 5.28% as S&P 500 enters correction, and for the week’s other big court ruling, see Bill 21 Supreme Court ruling due 27 November.

Bhudev Bhagaliya is an experienced and senior journalist who has carved a distinct niche for himself in the world of Hindi journalism through his profound understanding and precise writing style. With over two decades of experience in the field of journalism, he has held key responsibilities at Dainik Hindustan for 12 years and at Amar Ujala for one year. Currently, he serves as the Content Editor for the Jagrook Youth News newspaper and portal, where he plays a crucial role in ensuring the quality and credibility of the news content. Bhudev Bhagaliya consistently writes about issues that help raise awareness within society and among the younger generation.